Insider Transactions in Q4 2024 at Longboard Pharmaceuticals, Inc. (LBPH)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 02
2024
|
Randall Kaye Executive Vice President & CMO |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
30,554
-100.0%
|
$1,833,240
$60.0 P/Share
|
|
Dec 02
2024
|
Kevin Robert Lind President and CEO |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
363,740
-100.0%
|
$21,824,400
$60.0 P/Share
|
|
Nov 19
2024
|
Randall Kaye Executive Vice President & CMO |
BUY
Exercise of conversion of derivative security
|
Direct |
30,554
+38.66%
|
$183,324
$6.0 P/Share
|
|
Nov 13
2024
|
Kevin Robert Lind President and CEO |
SELL
Bona fide gift
|
Direct |
80,000
-18.03%
|
-
|
|
Nov 13
2024
|
Kevin Robert Lind President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,808
+2.81%
|
$38,424
$3.12 P/Share
|
|
Oct 15
2024
|
Randall Kaye Executive Vice President & CMO |
SELL
Open market or private sale
|
Direct |
16,667
-48.19%
|
$983,353
$59.03 P/Share
|
|
Oct 15
2024
|
Randall Kaye Executive Vice President & CMO |
BUY
Exercise of conversion of derivative security
|
Direct |
16,667
+32.52%
|
$66,668
$4.35 P/Share
|